Subscribe to our Newsletters !!

    Kumar Jeetendra

    Safety to… Biosafety

    Safety is the most commonly being used word nowadays by every individual at each and every level though it has been an essential parameter for the ages. Different Viruses such as SARS/COVID and the disease it causes are among mankind’s greatest enemy today. As a part of this battle, biosecurity is of vital importance, since

    Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

    Basel, Switzerland, 07 March 2022 – Lonza has expanded its renowned human stem cell offerings to provide human cord blood CD34+ hematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, meeting a critical and rapidly expanding market need. Lots in a range of sizes are also now available with high-resolution HLA-type information, removing the requirement

    Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

    07 March 2022, Oxford and London – Life Science Newswire – Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC). Current treatment options for NSCLC are limited,

    No diet suits all: Optimise nutrition as you age

    As the world celebrates womanhood on March 8th, let’s pause to understand what healthy eating looks like for a woman. Literally. What should we be feeding our bodies so that we can enjoy good health throughout the changing stages of our lives? Whether you’re a student attending online classes or a corporate honcho working from

    Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram.

    8th March 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. The approved ANDA is therapeutically equivalent to the reference

    Are you looking out for solutions to your critical demands of high-pressure fluid processing application in the Biopharma industry?

    Know more About -Imaweld™ TPE Braided Tubing- designed to meet the demands of the pressurized critical applications. Imaweld™ TPE Braided Tubing, a specially designed product with the THERMOPOLYMER material which is worldwide accepted in the bioprocess industry for the high press fluid processing applications. Imaweld™ TPE Braided Tubing is translucent braided tube manufactured in cleanroom

    Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions

    Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD). “We have established an approach that transforms real-world, in-human treatment outcomes and

    Alembic Pharmaceuticals receives USFDA Tentative Approval for Macitentan Tablets, 10 mg.

    14th March 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Opsumit Tablets, 10 mg, of

    Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 – HaystackAnalytics Insights

    Mumbai, 23 March 2022: HaystackAnalytics, a Mumbai based health-tech startup, supported by the Department of Science & Technology, Govt of India, healthcare veterans like Dr Velumani, and private players such as GE Healthcare and Intel India Startup Program, reported an alarming 49% increase in the number of TB infections across the country, which largely remain

    Hester Biosciences Limited, India’s 2nd Largest Poultry Vaccine Manufacturer, ventures into the Pet Care Industry

    22 March 2022: Hester Biosciences Limited is all set to expand into the rapidly growing Pet Care sector this April. India has the fastest-growing pet care market worldwide, with it growing by 14% in 2022, making this an exciting and valuable opportunity for the poultry vaccine giant. Hester’s comprehensive knowledge of animal biology, cutting-edge R&D